openPR Logo
Press release

Orthobiologics Market Size Share - Emerging Evolution, Advancement, Industry Trends and Forecast 2018 - 2025

06-27-2018 02:39 PM CET | Health & Medicine

Press release from: Coherent Market Insights Biotechnology

Orthobiologics Market Size Share - Emerging Evolution,

Orthobiologics are substances used to heal injuries such as fractures and injured muscles, ligaments, and tendons within a short period of time. Orthobiologics are made from substances that naturally occur in the body. Some examples of orthobiologics are bone grafts, autologous blood, autologous conditioned serum, platelet rich plasma, growth factors, and stem cells.

Increasing prevalence of injury and facture due to falls and road accidents are expected to augment growth of the orthobiologics market

According to World Health Organization (WHO), 2017, fatal falls are the second-leading cause of accidental injury and factures worldwide. Every year around 646000 individuals die from falls, globally. Increasing incidence of fall is expected to increase the chances of fractures, which in turn, is expected to create a highly conductive environment for growth of the orthobiologics market over the forecast period.

Request for Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1306

According to World Health Organization (WHO), in 2017, around 1.25 million deaths were recorded and 20 to 50 million people suffered from severe injuries and fractures. Increasing prevalence of factures due to road accidents is expected to boost growth of the orthobiologics market in the near future. According to National Institute of Health (NIH), in 2016, around 8.5%, accounting for around 617 million of the world population was aged 65 years and above. Growing geriatric population, which is highly susceptible to injuries and fractures due to fragile skeletal framework, is increasing the prevalence of orthopedic disorders, in turn, driving growth of the orthobiologics market. The major factor restraining market growth is the high cost associated with orthobiologics-based treatments.

Global Orthobiologics Market Taxonomy

The global orthobiologics market is segmented on the basis of product type, application, and end user.

By Product Type

Demineralized Bone Matrix (DBM)

Allograft

Bone Morphogenetic Protein (BMP)

Viscosupplementation Products

Synthetic Bone Substitutes

Stem Cell Therapy

By Application

Osteoarthritis and Degenerative Arthritis

Spinal Fusion

Fracture Recovery

Soft Tissue Injuries

Maxillofacial and Dental Applications

 By End User

Hospitals

Ambulatory Care Centers

Dental Clinics

Request for TOC : https://www.coherentmarketinsights.com/ongoing-insight/toc/1306

North America is expected to hold a dominant position due to rapid development of new innovative products by key players present in region

North America is expected to hold a dominant position in the orthobiologics market due to rampant research activities and rapid development of innovative products by key players present in the region. For instance, in 2015, NuVasive Inc.—U.S.-based company—launched its new innovative biologics technology, AttraX Putty, which is a synthetic bone graft, indicated in posterolateral spinal surgery as an autograft extender. Asia Pacific is expected to witness rapid growth, owing to growing geriatric population in the region. According to The United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), 2016, the Asia Pacific region recorded around 60 percent of the geriatric population across the globe. The region recorded around 547 million people aged 65 years and above, which is projected to reach up to 1.3 billion by 2050.

Major players in the market are focusing on inorganic growth strategies such as mergers and acquisitions, to enhance their foothold in the global orthobiologics market. For instance, in May 2015, Bone Biologics Corp. collaborated with the University of California for the development of Nell-1, a bone growth stimulator orthobiological product.

Key players operating in the orthobiologics market include Medtronic Plc, DePuy Synthes, Inc., Zimmer Biomet Holdings, Inc., Bone Biologics Corp, Harvest Technologies Corporation, Globus Medical, Inc., Smith & Nephew plc. NuVasive Inc., Stryker Corporation, and Genzyme.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Orthobiologics Market Size Share - Emerging Evolution, Advancement, Industry Trends and Forecast 2018 - 2025 here

News-ID: 1100462 • Views:

More Releases from Coherent Market Insights Biotechnology

Wound Care Biologics Market 2026: Global Industry Insights And Growth Analysis By Top Players - Smith & Nephew Plc., Organogenesis, Integra Lifesciences Holdings Corporation
Wound Care Biologics Market 2026: Global Industry Insights And Growth Analysis B …
Wound care biologic products facilitates in innate repair mechanisms, and involves the use of active biological agents such as animal and plant-derived active biomolecules, which exhibit antioxidant, antimicrobial, or anti-inflammatory properties. Wound care biologic dressings are increasingly being used in post surgeries and severe trauma cases as they provide moist healing environment aiding heat loss, protein and electrolyte loss for faster healing, and prevent bacterial contamination. Biologic skin substitute products
Bone Marrow Transplant Market 2018 With Major Key Players STEMCELL Technologies, Merck Millipore Corporation, Sanofi-Aventis , AllCells, ReachBio
Bone Marrow Transplant Market 2018 With Major Key Players STEMCELL Technologies, …
Bone marrow transplant is a medical procedure to replace bone marrow damaged or destroyed by disease, infection, or chemotherapy. Bone marrow transplant procedure involves transplanting blood stem cells that travel to the bone marrow where they produce new blood cells and promote growth of new marrow. Bone marrow is the spongy, fatty tissue inside human bones, which creates the different parts of blood such as red blood cells that carry
Targeted Cancer Therapies Market Future and Technological Advancement To 2026 With Key Vendors Abbott Laboratories, Bayer AG, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, AstraZeneca PLC, OncoGenex Pharmaceuticals Inc., Pfizer
Targeted Cancer Therapies Market Future and Technological Advancement To 2026 Wi …
Targeted cancer therapies are drugs which block the growth and proliferation of cancer by interfering with specific molecules such as DNA or proteins, which are involved in the growth or expansion of cancerous cells. Targeted cancer therapies differ in several ways from standard chemotherapy. Standard chemotherapy act on all rapidly dividing cancerous cells as well as normal cells, while targeted cancer therapies act on specific molecular targets that are associated
Insulin Biosimilars Market Size, Growth and SWOT Analysis by Key Players Boehringer Ingelheim, Pfizer Inc., Biocon, Merck & Co., Mylan N.V., Eli Lilly & Co., Wockhardt Limited, NOVO Nordisk A/S, Sanofi S.A
Insulin Biosimilars Market Size, Growth and SWOT Analysis by Key Players Boehrin …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million

All 5 Releases


More Releases for Orthobiologics

Orthobiologics Market Innovations in Regenerative Medicine
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Orthobiologics Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many
Key Orthobiologics Devices And Equipment Market Trend for 2025-2034: Biodegradab …
What Is the Future Outlook for the Orthobiologics Devices And Equipment Market's Size and Growth Rate? In recent times, there has been steady growth in the size of the orthobiologics devices and equipment market. It is projected to rise from $5.74 billion in 2024 to $5.99 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth during the historical period include the introduction of
Key Orthobiologics Devices And Equipment Market Trend for 2025-2034: Biodegradab …
What Is the Future Outlook for the Orthobiologics Devices And Equipment Market's Size and Growth Rate? In recent times, there has been steady growth in the size of the orthobiologics devices and equipment market. It is projected to rise from $5.74 billion in 2024 to $5.99 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth during the historical period include the introduction of
Key Orthobiologics Devices And Equipment Market Trend for 2025-2034: Biodegradab …
What Is the Future Outlook for the Orthobiologics Devices And Equipment Market's Size and Growth Rate? In recent times, there has been steady growth in the size of the orthobiologics devices and equipment market. It is projected to rise from $5.74 billion in 2024 to $5.99 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth during the historical period include the introduction of
Global Orthobiologics Sales Market Report 2017
In this report, the global Orthobiologics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. This report studies Orthobiologics in Global Sales market , especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with sales, price, revenue and market
Orthobiologics Market USD 5.8 Billion by 2020
Orthobiologics Market 2013-2020 report estimates the global orthobiologics market to reach nearly USD 5.8 Billion in 2020, at a CAGR of 6.2% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Orthobiologics Market 2013-2020 report https://www.ihealthcareanalyst.com/report/orthobiologics-market/ The global orthobiologics market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global orthobiologics market segmentation is based on product types (allograft, bone